ACER
Acer Therapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Acer Therapeutics Inc is a pharmaceutical company that acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need.
Market Cap: 143 Million
Primary Exchange: NASDAQ Capital Market
Website: https://www.acertx.com
Shares Outstanding: 7.5 Million
Float: 2.05 Million
Dividend: 0.0 (0.0%)
Beta: 2.519044
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 43.9 Thousand
Ethical Flags
Longest drawdown: 1689 trading days
From: 2013-02-05 To: 2019-10-18
Lowest Point:
Acer Therapeutics: Concerns Prior To Upcoming PDUFA Date
via: SeekingAlpha at 2019-06-11 12:00:30:000
Acer Therapeutics Inc. (ACER) ("Acer" or the "Company") is a pharmaceutical company headquartered in Newton, Massachusetts, focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening orphan or ultra-orphan diseases with significant unmet… read more...
Acer Therapeutics: Concerns Prior To Upcoming PDUFA Date
via: SeekingAlpha at 2019-06-11 12:00:30:000
Acer Therapeutics Inc. (ACER) ("Acer" or the "Company") is a pharmaceutical company headquartered in Newton, Massachusetts, focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening orphan or ultra-orphan diseases with significant unmet… read more...
Acer Therapeutics: Concerns Prior To Upcoming PDUFA Date
via: SeekingAlpha at 2019-06-11 12:00:30:000
Acer Therapeutics Inc. (ACER) ("Acer" or the "Company") is a pharmaceutical company headquartered in Newton, Massachusetts, focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening orphan or ultra-orphan diseases with significant unmet… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-09-21 | 10.355527 | 1.0 | 10.355527 | |||
| 2015-09-29 | 8.0 | 1.0 | 8.0 |